Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC
University of Chicago
University of Chicago
Shandong Cancer Hospital and Institute
Royal Marsden NHS Foundation Trust
Shandong Cancer Hospital and Institute
Fujian Medical University Union Hospital
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Danish Breast Cancer Cooperative Group